Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

March 31, 2012

Study Completion Date

April 30, 2012

Conditions
LymphedemaBreast Cancer
Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

California Breast Cancer Research Program

OTHER

lead

Stanford University

OTHER

NCT00383604 - Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2 | Biotech Hunter | Biotech Hunter